Skip to main content Help with accessibility Skip to main navigation

Ozanimod

Indication

Treating moderately to severely active ulcerative colitis - NICE TA828

NICE TA828 - Ozanimod for treating moderately to severely active ulcerative colitis

Red

Brand:

Nice TA:

828

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:
Gastro-intestinal system

Background

1.1 Ozanimod is recommended as an option for treating moderately to severely active ulcerative colitis in adults, only if:

  • conventional treatment cannot be tolerated or is not working well enough and infliximab is not suitable, or

  • biological treatment cannot be tolerated or is not working well enough, and

  • the company provides it according to the commercial arrangement.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

Red
Red
Red
Red
Red
Red
Red
Red
What do the colours mean?

Last Updated: 14 - Nov - 2022